Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immune Checkpoint Inhibition in GBM Primed with Radiation by Engineered Extracellular Vesicles
Tian Tian, Ruyu Liang, Gülşah Erel‐Akbaba, et al.
ACS Nano (2022) Vol. 16, Iss. 2, pp. 1940-1953
Open Access | Times Cited: 96

Showing 1-25 of 96 citing articles:

Engineered exosomes from different sources for cancer-targeted therapy
Menghui Zhang, Shengyun Hu, Lin Liu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 196
Current Strategies for Exosome Cargo Loading and Targeting Delivery
Haifeng Zeng, Shaoshen Guo, Xuancheng Ren, et al.
Cells (2023) Vol. 12, Iss. 10, pp. 1416-1416
Open Access | Times Cited: 143
Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
Chaozheng Zhou, Shengkun Peng, Anqi Lin, et al.
EClinicalMedicine (2023) Vol. 59, pp. 101967-101967
Open Access | Times Cited: 94
Immunotherapy: a promising approach for glioma treatment
Feroza Yasinjan, Xing Yang, Huayue Geng, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 80
Recent Advances and Challenges in Cancer Immunotherapy
Chelsea Peterson, Nathan Denlinger, Yiping Yang
Cancers (2022) Vol. 14, Iss. 16, pp. 3972-3972
Open Access | Times Cited: 74
Radiation-induced tumor immune microenvironments and potential targets for combination therapy
Siyu Guo, Yihan Yao, Yang Tang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 63
Nucleic acid drug vectors for diagnosis and treatment of brain diseases
Zhiguo Lü, Jie Shen, H. J. Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 60
Exosomes as smart drug delivery vehicles for cancer immunotherapy
Huan Zhang, Simiao Wang, Man Sun, et al.
Frontiers in Immunology (2023) Vol. 13
Open Access | Times Cited: 54
Tumor immune escape: extracellular vesicles roles and therapeutics application
Mahdi Ahmadi, Reza Abbasi, Jafar Rezaie
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 24
Brain-Targeting Drug Delivery Systems: The State Of The Art In Treatment Of Glioblastoma
Bo Sun, Rong Li, Ning Ji, et al.
Materials Today Bio (2025) Vol. 30, pp. 101443-101443
Open Access | Times Cited: 2
Extracellular vesicles in cancer therapy
Shizhen Emily Wang
Seminars in Cancer Biology (2022) Vol. 86, pp. 296-309
Open Access | Times Cited: 44
Nanomedicine embraces cancer radio-immunotherapy: mechanism, design, recent advances, and clinical translation
Haonan Li, Qiang Luo, Hu Zhang, et al.
Chemical Society Reviews (2022) Vol. 52, Iss. 1, pp. 47-96
Closed Access | Times Cited: 42
Controlling Disassembly of Paramagnetic Prodrug and Photosensitizer Nanoassemblies for On-Demand Orthotopic Glioma Theranostics
Ruibing An, Lingjun Liu, Shixuan Wei, et al.
ACS Nano (2022) Vol. 16, Iss. 12, pp. 20607-20621
Closed Access | Times Cited: 40
Engineered EVs designed to target diseases of the CNS
Lisa Nieland, Shadi Mahjoum, Emily Grandell, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 493-506
Open Access | Times Cited: 40
Nanoparticles Hitchhike on Monocytes for Glioblastoma Treatment after Low-Dose Radiotherapy
Jing Kuang, Zhi‐Yong Rao, Di‐Wei Zheng, et al.
ACS Nano (2023) Vol. 17, Iss. 14, pp. 13333-13347
Closed Access | Times Cited: 40
Radiation-Triggered Selenium-Engineered Mesoporous Silica Nanocapsules for RNAi Therapy in Radiotherapy-Resistant Glioblastoma
Xianglong Tang, Zhen Wang, Yandong Xie, et al.
ACS Nano (2023) Vol. 17, Iss. 4, pp. 4062-4076
Closed Access | Times Cited: 32
Multifunctional nanocomposites modulating the tumor microenvironment for enhanced cancer immunotherapy
Prashant Sharma, Mario Otto
Bioactive Materials (2023) Vol. 31, pp. 440-462
Open Access | Times Cited: 32
Engineered small extracellular vesicle‑mediated NOX4 siRNA delivery for targeted therapy of cardiac hypertrophy
Jiyoung Kang, Dasom Mun, Yumin Chun, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 10
Open Access | Times Cited: 26
The Landscape of Biomimetic Nanovesicles in Brain Diseases
Qing You, Fuming Liang, Gege Wu, et al.
Advanced Materials (2023) Vol. 36, Iss. 7
Closed Access | Times Cited: 24
Engineering exosomes to reshape the immune microenvironment in breast cancer: Molecular insights and therapeutic opportunities
Jilong Cao, Gang Lv, Wei Fang
Clinical and Translational Medicine (2024) Vol. 14, Iss. 4
Open Access | Times Cited: 14
Smart Nanoscale Extracellular Vesicles in the Brain: Unveiling their Biology, Diagnostic Potential, and Therapeutic Applications
Akanksha Onkar, Fatima Khan, Anshika Goenka, et al.
ACS Applied Materials & Interfaces (2024) Vol. 16, Iss. 6, pp. 6709-6742
Closed Access | Times Cited: 10
Glioblastoma extracellular vesicles modulate immune PD-L1 expression in accessory macrophages upon radiotherapy
Markus Schweiger, Zohreh Amoozgar, Pierre Repiton, et al.
iScience (2024) Vol. 27, Iss. 2, pp. 108807-108807
Open Access | Times Cited: 8
Defining tropism and activity of natural and engineered extracellular vesicles
Wooil Choi, Dong Jun Park, Brian P. Eliceiri
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 8
Brain‐targeting drug delivery systems
Peixin Liu, Chen Jiang
Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology (2022) Vol. 14, Iss. 5
Closed Access | Times Cited: 35
Combined Immunotherapy Improves Outcome for Replication-Repair-Deficient (RRD) High-Grade Glioma Failing Anti–PD-1 Monotherapy: A Report from the International RRD Consortium
Anirban Das, Nicholas R. Fernandez, Adrian Levine, et al.
Cancer Discovery (2023) Vol. 14, Iss. 2, pp. 258-273
Open Access | Times Cited: 21
Page 1 - Next Page

Scroll to top